IL13 and Alzheimer disease: Additionally, genetic variations in immune-related genes, including those regulating interleukin (IL)-4, IL-13, and thymic stromal lymphopoietin (TSLP), can contribute to dysregulated type 2 immune responses and drive chronic inflammation and AD [6,7,8].